These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1961131)

  • 1. Intestinal absorption of aspartame decomposition products in adult rats.
    Lipton WE; Li YN; Younoszai MK; Stegink LD
    Metabolism; 1991 Dec; 40(12):1337-45. PubMed ID: 1961131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of hybrid peptide synthetases for the production of alpha-l-aspartyl-l-phenylalanine, a precursor for the high-intensity sweetener aspartame.
    Duerfahrt T; Doekel S; Sonke T; Quaedflieg PJ; Marahiel MA
    Eur J Biochem; 2003 Nov; 270(22):4555-63. PubMed ID: 14622284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of aspartame and its L-phenylalanine methyl ester decomposition product by the porcine gut.
    Burgert SL; Andersen DW; Stegink LD; Takeuchi H; Schedl HP
    Metabolism; 1991 Jun; 40(6):612-8. PubMed ID: 1865825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of aspartame by human and pig intestinal microvillar peptidases.
    Hooper NM; Hesp RJ; Tieku S
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):635-9. PubMed ID: 8141778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal hydrolysis of aspartylphenylalanine--the metabolic product of aspartame.
    Tobey NA; Heizer WD
    Gastroenterology; 1986 Oct; 91(4):931-7. PubMed ID: 3743970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations in normal adults.
    Stegink LD; Filer LJ; Bell EF; Ziegler EE; Tephly TR
    Metabolism; 1989 Apr; 38(4):357-63. PubMed ID: 2566887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated ingestion of aspartame-sweetened beverage: effect on plasma amino acid concentrations in normal adults.
    Stegink LD; Filer LJ; Baker GL
    Metabolism; 1988 Mar; 37(3):246-51. PubMed ID: 3343933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame.
    Hjelle JJ; Dudley RE; Marietta MP; Sanders PG; Dickie BC; Brisson J; Kotsonis FN
    Pharmacology; 1992; 44(1):48-60. PubMed ID: 1553388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between mucosal hydrolysis and transport of two phenylalanine dipeptides.
    Silk DB; Nicholson JA; Kim YS
    Gut; 1976 Nov; 17(11):870-6. PubMed ID: 12068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racemization of aspartic acid and phenylalanine in the sweetener aspartame at 100 degrees C.
    Boehm MF; Bada JL
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5263-6. PubMed ID: 6591191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A metabolite of aspartame inhibits angiotensin converting enzyme.
    Grobelny D; Galardy RE
    Biochem Biophys Res Commun; 1985 Apr; 128(2):960-4. PubMed ID: 2986632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated ingestion of aspartame-sweetened beverages: further observations in individuals heterozygous for phenylketonuria.
    Stegink LD; Filer LJ; Bell EF; Ziegler EE; Tephly TR; Krause WL
    Metabolism; 1990 Oct; 39(10):1076-81. PubMed ID: 2215254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide synthesis of aspartame precursor using organic-solvent-stable PST-01 protease in monophasic aqueous-organic solvent systems.
    Tsuchiyama S; Doukyu N; Yasuda M; Ishimi K; Ogino H
    Biotechnol Prog; 2007; 23(4):820-3. PubMed ID: 17480054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated ingestion of aspartame-sweetened beverage: effect on plasma amino acid concentrations in individuals heterozygous for phenylketonuria.
    Stegink LD; Filer LJ; Baker GL; Bell EF; Ziegler EE; Brummel MC; Krause WL
    Metabolism; 1989 Jan; 38(1):78-84. PubMed ID: 2909831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartame and aspartame derivatives effect human thrombin catalytic activity.
    Scheffler JE; Berliner LJ
    Biophys Chem; 2004 Dec; 112(2-3):285-91. PubMed ID: 15572260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice.
    Gul SS; Hamilton AR; Munoz AR; Phupitakphol T; Liu W; Hyoju SK; Economopoulos KP; Morrison S; Hu D; Zhang W; Gharedaghi MH; Huo H; Hamarneh SR; Hodin RA
    Appl Physiol Nutr Metab; 2017 Jan; 42(1):77-83. PubMed ID: 27997218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks.
    Ishii H; Koshimizu T; Usami S; Fujimoto T
    Toxicology; 1981; 21(2):91-4. PubMed ID: 7281205
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.